FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1976392245> ?p ?o ?g. }

• W1976392245 endingPage "761" @default.
• W1976392245 startingPage "754" @default.
• W1976392245 abstract "Background Despite widely reported clinical and preclinical studies of rapid antidepressant actions of glutamate N-methyl-D-aspartate (NMDA) receptor antagonists, there has been very little work examining the effects of these drugs in stress models of depression that require chronic administration of antidepressants or the molecular mechanisms that could account for the rapid responses. Methods We used a rat 21-day chronic unpredictable stress (CUS) model to test the rapid actions of NMDA receptor antagonists on depressant-like behavior, neurochemistry, and spine density and synaptic function of prefrontal cortex neurons. Results The results demonstrate that acute treatment with the noncompetitive NMDA channel blocker ketamine or the selective NMDA receptor 2B antagonist Ro 25-6981 rapidly ameliorates CUS-induced anhedonic and anxiogenic behaviors. We also found that CUS exposure decreases the expression levels of synaptic proteins and spine number and the frequency/amplitude of synaptic currents (excitatory postsynaptic currents) in layer V pyramidal neurons in the prefrontal cortex and that these deficits are rapidly reversed by ketamine. Blockade of the mammalian target of rapamycin protein synthesis cascade abolishes both the behavioral and biochemical effects of ketamine. Conclusions The results indicate that the structural and functional deficits resulting from long-term stress exposure, which could contribute to the pathophysiology of depression, are rapidly reversed by NMDA receptor antagonists in a mammalian target of rapamycin dependent manner. Despite widely reported clinical and preclinical studies of rapid antidepressant actions of glutamate N-methyl-D-aspartate (NMDA) receptor antagonists, there has been very little work examining the effects of these drugs in stress models of depression that require chronic administration of antidepressants or the molecular mechanisms that could account for the rapid responses. We used a rat 21-day chronic unpredictable stress (CUS) model to test the rapid actions of NMDA receptor antagonists on depressant-like behavior, neurochemistry, and spine density and synaptic function of prefrontal cortex neurons. The results demonstrate that acute treatment with the noncompetitive NMDA channel blocker ketamine or the selective NMDA receptor 2B antagonist Ro 25-6981 rapidly ameliorates CUS-induced anhedonic and anxiogenic behaviors. We also found that CUS exposure decreases the expression levels of synaptic proteins and spine number and the frequency/amplitude of synaptic currents (excitatory postsynaptic currents) in layer V pyramidal neurons in the prefrontal cortex and that these deficits are rapidly reversed by ketamine. Blockade of the mammalian target of rapamycin protein synthesis cascade abolishes both the behavioral and biochemical effects of ketamine. The results indicate that the structural and functional deficits resulting from long-term stress exposure, which could contribute to the pathophysiology of depression, are rapidly reversed by NMDA receptor antagonists in a mammalian target of rapamycin dependent manner." @default.
• W1976392245 created "2016-06-24" @default.
• W1976392245 creator A5002073103 @default.
• W1976392245 creator A5004477208 @default.
• W1976392245 creator A5007433475 @default.
• W1976392245 creator A5010721455 @default.
• W1976392245 creator A5077621462 @default.
• W1976392245 creator A5083475801 @default.
• W1976392245 creator A5087594298 @default.
• W1976392245 creator A5091240519 @default.
• W1976392245 creator A5091646209 @default.
• W1976392245 date "2011-04-01" @default.
• W1976392245 modified "2023-10-18" @default.
• W1976392245 title "Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure" @default.
• W1976392245 cites W1546686332 @default.
• W1976392245 cites W1970627396 @default.
• W1976392245 cites W1977430165 @default.
• W1976392245 cites W1988375440 @default.
• W1976392245 cites W1990583458 @default.
• W1976392245 cites W2002669733 @default.
• W1976392245 cites W2004331086 @default.
• W1976392245 cites W2005084361 @default.
• W1976392245 cites W2016098542 @default.
• W1976392245 cites W2017242154 @default.
• W1976392245 cites W2017727557 @default.
• W1976392245 cites W2019316537 @default.
• W1976392245 cites W2019871806 @default.
• W1976392245 cites W2020948229 @default.
• W1976392245 cites W2023081218 @default.
• W1976392245 cites W2023464568 @default.
• W1976392245 cites W2024636695 @default.
• W1976392245 cites W2030935953 @default.
• W1976392245 cites W2031231313 @default.
• W1976392245 cites W2032739515 @default.
• W1976392245 cites W2044710410 @default.
• W1976392245 cites W2047397795 @default.
• W1976392245 cites W2048398100 @default.
• W1976392245 cites W2048595403 @default.
• W1976392245 cites W2053472601 @default.
• W1976392245 cites W2063572710 @default.
• W1976392245 cites W2063783720 @default.
• W1976392245 cites W2066457796 @default.
• W1976392245 cites W2067152194 @default.
• W1976392245 cites W2076201141 @default.
• W1976392245 cites W2078678809 @default.
• W1976392245 cites W2079442110 @default.
• W1976392245 cites W2083739539 @default.
• W1976392245 cites W2084207424 @default.
• W1976392245 cites W2084850612 @default.
• W1976392245 cites W2086236919 @default.
• W1976392245 cites W2089351762 @default.
• W1976392245 cites W2109334244 @default.
• W1976392245 cites W2109694255 @default.
• W1976392245 cites W2121358117 @default.
• W1976392245 cites W2123329302 @default.
• W1976392245 cites W2137296158 @default.
• W1976392245 cites W2146978055 @default.
• W1976392245 cites W2149402043 @default.
• W1976392245 cites W2160383565 @default.
• W1976392245 cites W2170790660 @default.
• W1976392245 doi "https://doi.org/10.1016/j.biopsych.2010.12.015" @default.
• W1976392245 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3068225" @default.
• W1976392245 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21292242" @default.
• W1976392245 hasPublicationYear "2011" @default.
• W1976392245 type Work @default.
• W1976392245 sameAs 1976392245 @default.
• W1976392245 citedByCount "905" @default.
• W1976392245 countsByYear W19763922452012 @default.
• W1976392245 countsByYear W19763922452013 @default.
• W1976392245 countsByYear W19763922452014 @default.
• W1976392245 countsByYear W19763922452015 @default.
• W1976392245 countsByYear W19763922452016 @default.
• W1976392245 countsByYear W19763922452017 @default.
• W1976392245 countsByYear W19763922452018 @default.
• W1976392245 countsByYear W19763922452019 @default.
• W1976392245 countsByYear W19763922452020 @default.
• W1976392245 countsByYear W19763922452021 @default.
• W1976392245 countsByYear W19763922452022 @default.
• W1976392245 countsByYear W19763922452023 @default.
• W1976392245 crossrefType "journal-article" @default.
• W1976392245 hasAuthorship W1976392245A5002073103 @default.
• W1976392245 hasAuthorship W1976392245A5004477208 @default.
• W1976392245 hasAuthorship W1976392245A5007433475 @default.
• W1976392245 hasAuthorship W1976392245A5010721455 @default.
• W1976392245 hasAuthorship W1976392245A5077621462 @default.
• W1976392245 hasAuthorship W1976392245A5083475801 @default.
• W1976392245 hasAuthorship W1976392245A5087594298 @default.
• W1976392245 hasAuthorship W1976392245A5091240519 @default.
• W1976392245 hasAuthorship W1976392245A5091646209 @default.
• W1976392245 hasBestOaLocation W19763922452 @default.
• W1976392245 hasConcept C112592302 @default.
• W1976392245 hasConcept C126322002 @default.
• W1976392245 hasConcept C15744967 @default.
• W1976392245 hasConcept C160268369 @default.
• W1976392245 hasConcept C169760540 @default.
• W1976392245 hasConcept C169900460 @default.
• W1976392245 hasConcept C170493617 @default.
• W1976392245 hasConcept C17077164 @default.

• next